期刊文献+

转录相关锌带蛋白基因在肾癌组织中的表达 被引量:2

Expression of ZNRD1 protein in human renal cell carcinoma
原文传递
导出
摘要 目的研究转录相关锌带蛋白基因(ZNRD1)在肾癌及肾脏正常组织中的表达。方法应用免疫组化法,检测71例肾癌组织和24例癌旁正常肾脏组织中ZNRD1蛋白的表达,并分析ZNRD1蛋白表达与肾癌Gleason分级和临床分期的关系。应用逆转录聚合酶链反应(RT-PCR)和Western blot法,分别检测20例肾癌及癌旁正常肾脏组织中ZNRD1 mRNA和蛋白的表达。结果免疫组化染色结果显示,ZNRD1蛋自主要定位于细胞核。ZNRD1蛋白在24例肾癌及其相应的癌旁正常肾脏组织中的阳性表达率分别为91.7%(22/24)和20.8%(5/24),差异具有明显的统计学意义(P〈0.01)。ZNRD1蛋白的表达与肾癌Gleason分级和临床分期均无显著的相关性(均P〉0.05)。RT-PCR检测结果显示,ZNRD1 mRNA在肾癌组织中的相对表达量为0.6186,明显高于癌旁正常肾脏组织(0.4273,P〈0.01)。Western blot检测结果显示,ZRND1蛋白在肾癌组织中的相对表达量为0.5623,亦明显高于癌旁正常肾脏组织(0.3885,P〈0.01)。结论ZNRD1可能在肾癌的发生发展中发挥着重要作用。 Objective To investigate the expression of zinc ribbon domain-containingl (ZNRD1) in human renal cell carcinoma and normal kidney tissues. Methods The expression of ZNRD1 protein was examined by immunohistochemical staining in 71 renal cell carcinomas and 24 samples of normal kidney tissue. The correlation between the expressions of ZNRD1 protein and clinicopathologic features was analyzed. The expression of ZNRD1 mRNA and ZNRD1 protein was detected by quantitative reverse transcriptase-polymerase chain reaction (PT-PCR) and Western blot in 20 renal cell carcinomas and corresponding adjacent non-cancerous tissues. Results ZNRD1 protein was detected mostly in the cell nuclei by immunohistochemistry. The positive expression rate of ZNRD1 protein was 91.7% (22/24) in renal cell carcinomas and 20.8% (5/24) in the normal kidney tissues, with a statistically significant difference between cancer and normal kidney tissue (P 〈 0.01 ). However, no significant correlation was observed between ZNRD1 protein expression level and clinicopathologic features (P 〉 0.05 ). ZNRD1 mRNA expression level was significantly higher in renal cell carcinomas (0. 6186) than that in the normal kidney tissues (0. 4273 ) assessed by RT-PCR ( P 〈 0.01 ). The expression level of ZNRD1 protein by Western blot was 0. 5623 in renal cell carcinomas, significantly higher than that in normal kidney tissues (0. 3885 ,P 〈 0.01 ). Conclusion ZNRD1 gene and ZNRD1 protein may play an important role in the carcinogenesis of renal cell carcinoma. Further investigation is still needed.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2008年第11期821-824,共4页 Chinese Journal of Oncology
基金 基金项目:国家自然科学基金资助项目(30471726)
关键词 肾肿瘤 免疫组织化学 WESTERN BLOT RT-PCR ZNRD1 Renal neoplasms Immunohistochemistry Western blot RT-PCR ZNRD1
  • 相关文献

参考文献9

二级参考文献62

  • 1[1]Fan W,Wang Z,Kyzysztof F et al.A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class I region.Genomics,2000,63(1):139
  • 2[2]Fan W,Cai W,Parimoo S et al.Identification of seven new human MHC class I region genes around the HLA-F locus.Immunogenetics,1996,44(2):97
  • 3[3]Qian X,Jeon C,Yoon H et al.Structure of a new nucleic-acid-binding motif in eukaryotic transcriptional elongation factor TFIIS.Nature,1993,365(6443):277
  • 4[4]Chu TW,Capossela A,Coleman R et al.Cloning of a new "finger" protein gene (ZNF173) within the class I region of the human MHC.Genomics,1995,29(1):229
  • 5[5]Chen HT,Legault P,Glushka J et al.Structure of a (Cys3His) zinc ribbon,a ubiquitous motif in archaeal and eucaryal transcription.Protein Sci,2000,9(9):1743
  • 6[6]Grishin NV.C-terminal domains of Escherichia coli topoisomerase I belong to the zinc-ribbon superfamily.J Mol Biol,2000,299(5):1165
  • 7[7]McCoy C,McGee SB,Cornwell MM.The Wilms' tumor suppressor,WT1,inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.Cell Growth Differ,1999,10(6):377
  • 8[8]Hirose M.The role of Wilms' tumor genes.J Med Invest,1999 ,46(3-4):130
  • 9[9]Bartsevich VV,Juliano RL.Regulation of the MDR1 gene by transcriptional repressors selected using peptide combinatorial libraries.Mol Pharmacol,2000,58(1):1
  • 10McCoy C, McGee SB, Cornwell MM. The Wilms' tumor suppressor,WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter. Cell Growth Differ, 1999, 10: 377-386.

共引文献28

同被引文献16

  • 1吴峰,王清明,范国才,陈吉中,陈惠鹏.紫杉醇诱导MCF-7乳腺癌细胞凋亡的蛋白质组研究[J].中华肿瘤杂志,2006,28(6):418-421. 被引量:8
  • 2Liu W,Zhu J,Cao L,et al.Expression of hGC-1 is correhted with differentiafian of gastric carcinoma.Histopathology,2007,51:157-165.
  • 3Kim HK,Park WS,Kang SH,et al.Mitochondrial alterations in human gastric carcinoma cell line.Am J Physiol Ceil Physiol,2007,293:761-771.
  • 4Talcikawa M,Akiyama Y,Maruyama K,et al.Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.Oncol Rep,2006,16:705-711.
  • 5Yodfihara T,Kadota Y,Yoshimura Y,et al.Proteomic alteration in gastic adenocareinomas from Japanese patients.Mol Cancer,2006,5:75.
  • 6Huang Q,Huang Q,Chen W,et al.Identification of transgetin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology.J Cancer Res Clin Oncol,2008,134:1219-1227.
  • 7Yang YX,Xiao zo,Chen zc,et a.Proteome analysis of multidrug resistance in vincfistine-resistant human gastric cancer cell line SGC7901/VCR.Proteomics,2006.6:2009-2021.
  • 8Seevaratnam R,Patel BP,Hamadeh MJ.CoMparison of total protein concentration in skeletal mnscle as measured by the Bradford and Lowry assays.J Biochem,2009.145:791-797.
  • 9Galletti E,Magnani M,Renzulli ML,et al.Paclitaxel and docetaxel resistance:molecular mechanisms and development of new generation taxanes.ChemMadChem,2007,2:920-942.
  • 10Zhang X,Shrikhande U,Alicie BM,et al.Role of the protein tyrosine kinase Syk in regahting cell-cell adhesion and motility in breast cancer cells.Mol Cancer Res,2009,7:634-644.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部